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Dietary guidelines for irritable bowel syndrome are important for gastroenterologists, dietitians and 
people with IBS 
Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal disorders experienced by the 
general public. IBS is not a single disease but a syndrome defined by the presence of characteristic 
symptoms including abdominal pain and alterations in bowel habits
(1)
. Though IBS does not shorten life 
expectancy nor predispose to gastrointestinal cancer, it can profoundly impact quality of life and work 
productivity. IBS has been associated with increased rates of unnecessary diagnostic testing, surgical 
procedures and accounts for an extensive economic cost to direct and indirect healthcare expenditure
(2)
For decades, the cornerstones of IBS treatment have been establishing a trusting and empathic patient-
professional relationship and using medications targeting patients’ most bothersome symptoms. 
Increasingly, healthcare providers are under pressure to maximize efficiency and productivity, often at 
the expense of the patient-professional relationship. Further, many would argue that imaging and 
endoscopy have replaced taking of a thorough history and listening to patients regarding their IBS 
symptoms. Though over-the-counter and prescription medications can be useful in some, randomised 
controlled trials (RCTs) show that they yield therapeutic gains of 8-20% over placebo and typically 
improve symptoms in fewer than half of those treated
.    
(3)
Given the harsh realities facing many people with IBS, it is not difficult to understand why so many 
search for other solutions to address their symptoms. Surveys report that up to 80% of patients with IBS 
associate their symptoms with eating food
.  
(4)
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pathogenesis or management of IBS for many years. More recently, there has been mounting scientific 
evidence for the role of food in both the pathogenesis and treatment of IBS
(5)
. At present, the largest 
body of evidence supports dietary restriction of fermentable oligosaccharides, disaccharides, 
monosaccharides and polyols (FODMAPs) in IBS. The osmotic properties and byproducts of colonic 
fermentation of FODMAPs are thought to serve as important triggers for symptoms in IBS patients but 
not healthy individuals
(6,7)
The increase in research regarding the effect of food and diet in IBS has been remarkable, but at the 
same time has created challenges for gastroenterologists and dietitians who must keep abreast of the 
latest research findings in this area. Clinical guidelines are an opportunity for the totality of evidence to 
be critically reviewed to inform recommendations to be applied in practice for the benefit of patients. 
.  
The Gastroenterology Specialist Group of the British Dietetic Association have published evidence-based 
guidelines for the use of diet and probiotics in the management of IBS
(8,9)
. These are updates to the 
original guidelines published in 2012 that were read and applied by dietitians and gastroenterologists 
across the world and were widely cited by practitioners and researchers
 (10)
In these updated guidelines, 12 clinical questions were posed regarding topics ranging from healthy 
eating and lifestyle, milk and dairy exclusion, dietary fibre, the low FODMAP diet, gluten, probiotics and 
elimination diets/food hypersensitivity in IBS. The guidelines were informed by systematic review of the 
scientific literature in the these areas and 86 studies were used to generate 46 evidence statements, 15 








. The previous guidelines only included reference to studies of probiotics that were 
available in the United Kingdom, at that time totaling only five RCTs
(10)
. In contrast the current guidelines 
include RCTs of any probiotic, thus increasing the number of eligible studies to 35 RCTs, recognising the 
availability of probiotics beyond geographic boundaries (e.g. via the internet) and considerably widening 
the international applicability of the recommendations
(9)
. What is also novel is that, for the probiotic 
recommendations only, a systematic review of systematic reviews was adopted. This was because nine 
systematic reviews of probiotics in IBS have been published between 2008 and 2015, and acknowledging 
the futility of repeating a search for individual trials, RCTs were identified from those included in these 
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to the variations in microbiological characteristics that will impact on their clinical efficacy in IBS
(12)
. 
Instead a summary has been produced identifying which probiotics have been shown to be effective and 
for which symptoms in order to inform selection of the probiotics by practitioners and patients
(9)
Implementation of these evidence-based dietary guidelines has the potential to empower patients to 
better manage their IBS symptoms, whilst the increased demand for dietetic expertise can be met by 




. We recommend these guidelines are read in detail, applied 
internationally and the effectiveness of the dietary interventions evaluated in practice
(8,9)
 
. However, the 
publication of these guidelines is not the final word on dietary modification in IBS. What is clear is that 
there remains a need for further well-designed, large RCTs of a range of dietary interventions in IBS that 
address both mechanisms of action and clinical effectiveness, as well as the impact on a wider range of 
outcomes including nutrient intake, quality of life and gastrointestinal microbiology and immunology, 
and this can only be achieved with effective collaboration between gastroenterologists and specialist 
dietitians.  
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